Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Conditions

Lung Neoplasms 10Hematopoietic and Lymphatic System Neoplasm 7Prostatic Neoplasms 5Carcinoma, Non-Small-Cell Lung 5Urinary Bladder Neoplasms 4Colorectal Neoplasms 4Squamous Cell Carcinoma of Head and Neck 3Ovarian Neoplasms 3Hematopoietic and Lymphoid System Neoplasm 3Hematologic Neoplasms 3Breast Neoplasms 3Triple Negative Breast Neoplasms 2Mouth Neoplasms 2Melanoma 2Malignant Solid Neoplasm 2Leukemia, Myeloid, Acute 2Head and Neck Carcinoma 2Fallopian Tube Neoplasms 2Vulvar Neoplasms 1Uterine Neoplasms 1Uterine Cervical Neoplasms 1Urogenital Neoplasms 1Ureteral Neoplasms 1Tonsillar Neoplasms 1Tongue Neoplasms 1Teratoma 1Stomatitis 1Spondylitis, Ankylosing 1Psoriasis 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Etoposide 4Cisplatin 4lutetium Lu 177 dotatate 2fludarabine phosphate 2fludarabine 2Cyclophosphamide 2Bleomycin 2repotrectinib 1pegfilgrastim 1etoposide phosphate 1copper dotatate CU-64 1Watchful Waiting 1Vorinostat 1Teniposide 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Respiratory Physiological Phenomena 1Practice Guidelines as Topic 1Platinum 1Nivolumab 1Mesna 1Magnetic Resonance Spectroscopy 1Lutetium-177 1Lutetium 1Injections 1Immunotherapy 1Filgrastim 1Drug Therapy 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Neoplasms, Germ Cell and Embryonal × Practice Guidelines as Topic × Clear all
NCT03067181 2026-05-05

Active Surveillance, Bleomycin, Etoposide, Carboplatin or Cisplatin in Treating Pediatric and Adult Patients With Germ Cell Tumors

Children's Oncology Group

Phase 3 Recruiting
1,780 enrolled

Neoplasms, Germ Cell and Embryonal, Teratoma, Carcinoma, Embryonal, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡